Digital Health Drug Repository (DHDR)

The purpose of the DHDR is to provide health care providers access to clinically relevant drug and pharmacy service information in order to ensure the best possible medication history for a client. 

What is it?

The Digital Health Drug Repository (DHDR) represents the first foundational component of the Ministry of Health and Long-term Care’s Comprehensive Drug Profile Strategy (CDPS).

 

The DHDR contains dispensed drug events for all publicly funded drugs and pharmacy services, as well as monitored drugs.

 

DHDR Release 1 implements the FHIR DSTU2 standard, and in doing so reduces the number of extensions required for implementation.


Lite Service FHIR Tests


Note:  As Lite services are only simulations with a subset of functionality, there maybe be differences between the documentation and the implemented web service.  Please contact us at architecture@ehealthontario.on.ca if you have any questions.

 

  • DHDR R1 Lite Service end point: lite.innovation-lab.ca:9443/dispense-service

Standard

Interface/Interaction

Scenario(s) Involved

FHIR DSTU2

Search Medication Dispense

Get all medication dispensation records across all sources associated with a health care client (by Health Card Number)

Retrieve Medication Dispense

Retrieve a single medication dispensation record by its resource ID

 

 

Benefits

  • For Health Care Providers

    • Access to clinically relevant drug and pharmacy service information enabling Best Possible Medication History.
    • Better integration of available drug data through existing EMRs, provincial digital health assets, and other systems to quickly, securely, and efficiently access data to enable the Best Possible Medication history.
    • Improved collaboration between health care providers through sharing of patient clinical data.

    For Patients

    • Enhanced patient experience provided by better-informed health care providers.
    • Improved care through more timely access to records, allowing providers more time for diagnosis, treatment, and communication with the patient.
    • Improved patient outcomes and decreased risk of adverse drug events.
    • Enhanced patient safety and continuity of care.